Multifocal Small Bowel Carcinoid Evaluation by 68Ga-DOTATATE PET

被引：5
作者：
Clark, Michael [1 ]
Nathan, Mark [1 ]
Broski, Stephen [1 ]
机构：
[1] Mayo Clin, Dept Radiol, Div Nucl Med, 200 First St SW, Rochester, MN 55905 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 04期
关键词：
neuroendocrine; carcinoid; Ga-68-DOTATATE PET/CT; somatostatin receptor; NEUROENDOCRINE TUMORS; IN-111-DTPA-OCTREOTIDE; MANAGEMENT;
D O I：
10.1097/RLU.0000000000002487
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. Ga-68-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using Ga-68-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of Ga-68-DOTATATE PET/CT compared with CT and In-111-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized.
引用
收藏
页码：E308 / E310
页数：3
相关论文
共 14 条
  • [1] Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
    Antunes, P.
    Ginj, M.
    Zhang, H.
    Waser, B.
    Baum, R. P.
    Reubi, J. C.
    Maecke, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (07) : 982 - 993
  • [2] Burke AP, 1997, CANCER-AM CANCER SOC, V79, P1086, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1086::AID-CNCR5>3.0.CO
  • [3] 2-E
  • [4] 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
    Deppen, Stephen A.
    Blume, Jeffrey
    Bobbey, Adam J.
    Shah, Chirayu
    Graham, Michael M.
    Lee, Patricia
    Delbeke, Dominique
    Walker, Ronald C.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 872 - 878
  • [5] Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
    Deppen, Stephen A.
    Liu, Eric
    Blume, Jeffrey D.
    Clanton, Jeffrey
    Shi, Chanjuan
    Jones-Jackson, Laurie B.
    Lakhani, Vipul
    Baums, Richard P.
    Berlin, Jordan
    Smith, Gary T.
    Graham, Michael
    Sandler, Martin P.
    Delbeke, Dominique
    Walker, Ronald C.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (05) : 708 - 714
  • [6] High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
    Hofman, Michael S.
    Kong, Grace
    Neels, Oliver C.
    Eu, Peter
    Hong, Emily
    Hicks, Rodney J.
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2012, 56 (01) : 40 - 47
  • [7] From the archives of the AFIP - Gastrointestinal carcinoids: Imaging features with clinicopathologic comparison
    Levy, Angela D.
    Sobin, Leslie H.
    [J]. RADIOGRAPHICS, 2007, 27 (01) : 237 - U19
  • [8] Laparoscopic surgical exploration is an effective strategy for locating occult primary neuroendocrine tumors
    Massimino, Kristen P.
    Han, Esther
    Pommier, SuEllen J.
    Pommier, Rodney F.
    [J]. AMERICAN JOURNAL OF SURGERY, 2012, 203 (05) : 628 - 631
  • [9] MOERTEL CG, 1961, CANCER-AM CANCER SOC, V14, P901, DOI 10.1002/1097-0142(196109/10)14:5<901::AID-CNCR2820140502>3.0.CO
  • [10] 2-Q
12